Rifamexil

N/A

Report date: 2023/01/14 16:58:45

Base Information

Drug NameRifamexil
Drug Alias NameMDL-62769
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein synthesis inhibitors
TargetsNot applicable
Therapy Area/IndicationsMycobacterium avium-intracellulare Infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAventis
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAventis
Active IndicationsN/A
Inactive IndicationsMycobacterium avium-intracellulare Infection

Other Information

ATC CodeN/A
Related LinksN/A